Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

pfizer PARP-Inhibitor Combination Therapies: Personalized Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

Pfizer

General Area of Interest for this RFP: Projects that will be considered for Pfizer support will focus on increasing healthcare professional awareness and knowledge in the following five (5) areas:

1. Personalized treatment in mCRPC: Understanding the rationale for PARP inhibitor combinations (including the MOA, latest clinical data, treatment sequencing) and identifying the optimal patient for PARP inhibitor therapy in mCRPC. Tools for patient counselling and shared decision making are also of interest.

2. Improved genetic and biomarker testing: Foster best practices in ordering, interpreting, and applying genetic and biomarker test results in clinical practice. Understand and explain the impact to patients (including germline and somatic testing and implementing reflex/mainstream testing). Increase awareness of the Canadian Urological Association (CUA) genetic testing guidelines for prostate cancer.

3. Enhanced multidisciplinary collaboration in clinical practice: Promote integration of care and communication between multidisciplinary team members managing mCRPC, including specialists (e.g. medical oncologists, urologists, uro-oncologists, radiation oncologists, pathologists) and health professionals (e.g. nurses, nurse practitioners, general practitioners in oncology (GPOs), pharmacists, genetic counsellors).

4. Management of PARP inhibitor therapy and side effects: Education on initiating treatment and preventing, monitoring, and managing side effects; including the role of patient counselling and of multi-disciplinary team members to optimize patient outcomes.

5. Expand education for community and rural HCPs involved in treating mCRPC: Tailor education to integrate the latest data and treatment advancements based on the unmet needs specific to treatment setting; connect community HCPs with specialists in their regions and foster collaboration between academic and community centers.

Examples of educational formats that will be considered under this RFP include but are not limited to:

o Peer-to-peer education

o On-agenda educational sessions during live conferences

o Satellite symposia

o Expert interviews recorded at live conferences, conference coverage reviews

o Online articles, newsletter articles, training courses, webinars

o Social media posted & linked content

o Videos, podcasts, infographics, animations It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Specialties

Cancer

Others

Oncology

Eligibility Requirements

Geographic Scope/Location of Project:

Canada

Applicant Eligibility Criteria

• The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

• Only organizations are eligible to receive grants, not individuals or physician-owned medical practices.

• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.

Eligible Countries:

Canada

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Sponsor Type: Corporate

Address: 66 Hudson Boulevard East New York, NY 10001-2192 USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity